COLLAGEN STOCK ADVANCES 17% TO 19-3/4 IN AUGUST AS FIRM PREDICTS 1997 IMPROVEMENT FROM AESTHETIC TECHNOLOGIES BUSINESS; O-T-C INDEX RECOUPS 4.4%
This article was originally published in The Gray Sheet
Executive Summary
Collagen's ability to weather lower Contigen incontinence implant sales in fiscal 1996, combined with the firm's predicted improvement in operating income in 1997, apparently helped inspire investor confidence in the stock. The issue reversed a two month slide and advanced 2-7/8 points, or 17%, to 19-3/4 in August, regaining some ground it relinquished in June and July, when it lost more than 20% of its value.